IL-23R

IL-23R

IL-23R 분자 정보

Molecule Name
Interleukin 23 Receptor
분자 별명
IL-23 R,IL-23 Receptor
Drug Development Progress
임상 약물 수2
시판 약물 수1
최고 연구 개발 단계Approved
표적 별명
IL-23 receptor,IL23R,Interleukin 23 Receptor,Interleukin-23 Receptor,IL-23R
분자 배경
Interleukin 23 receptor (IL-23R) is a type I cytokine receptor, and IL-23R pairs with the receptor molecule IL12RB1/IL12Rbeta1, and both are required for IL23A signaling. Also, IL-23R associates constitutively with Janus kinase 2 (JAK2), and binds to transcription activator STAT3 in a ligand-dependent manner. Furthermore, IL-23R mediates T-cells, NK cells and possibly certain macrophage/myeloid cells stimulation probably through activation of the Jak-Stat signaling cascade. As for IL-23, it may be responsible for autoimmune inflammatory diseases and be important for tumorigenesis.

제품 문의

Asset Licensing Opportunity
Resources

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
BezisterimHE-3286; NE-3107Phase 3 ClinicalHarbor Therapeutics Inc
Alzheimer Disease; Arthritis, Rheumatoid; Brain Injuries, Traumatic; Colitis, Ulcerative; Diabetes Mellitus, Type 2; Insulin Resistance; Parkinson Disease; Post-Acute COVID-19 Syndrome
상세
PN-232PN-232; JNJ75105186Phase 1 ClinicalProtagonist Therapeutics Inc
상세

시판 약물 정보

영어 이름연구 코드연구 개발 단계회사가장 빠른 브랜드 이름가장 빠른 승인 국가가장 빠른 적응증가장 빠른 승인 회사가장 빠른 승인 날짜적응증임상 시험
IcotrokinraPN-235; JNJ-2113; JNJ-77242113-AAC; PN-21235; JNJ-77242113ApprovedProtagonist Therapeutics IncICOTYDEUnited StatesPlaque psoriasisJanssen Biotech Inc2026-03-17
Arthritis, Psoriatic; Colitis, Ulcerative; Crohn Disease; Erythrodermic psoriasis; Generalised pustular psoriasis; Plaque psoriasis; Psoriasis
상세
Customer Reviews